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State of the Science

Driving in Early-Stage Alzheimer’s Disease
An Integrative Review of the Literature
Rebecca L. Davis, PhD, RN; and Jennifer M. Ohman, DNP, RN, AGNP-C

ABSTRACT

One of the most difficult decisions for individuals with Alzheimer’s disease (AD) is when to stop driving.
Because driving is a fundamental activity linked to socialization, independent functioning, and wellbeing, making the decision to stop driving is not easy. Cognitive decline in older adults can lead to getting lost while driving, difficulty detecting and avoiding hazards, as well as increased errors while driving
due to compromised judgment and difficulty in making decisions. The purpose of the current literature
review was to synthesize evidence regarding how individuals with early-stage AD, their families, and providers make determinations about driving safety, interventions to increase driving safety, and methods
to assist cessation and coping for individuals with early-stage AD. The evidence shows that changes in
driving ability start early and progress throughout the trajectory of AD. Some individuals with mild cognitive impairment or early-stage AD may be safe to drive for a period of time. Support groups aimed at
helping with the transition have been shown to be helpful for individuals who stop driving. Research and
practice must support interventions to help individuals maintain safety while driving, as well as cope
with driving cessation.
[Res Gerontol Nurs. 20xx; x(x):xx–xx.]

More than 5.3 million individuals are diagnosed with
Alzheimer’s disease (AD) in the United States (Alzheimer’s
Association, 2015). AD is the most common cause of
dementia, with symptoms ranging from memory loss in
the early stages to severe cognitive and functional disability
in the end stages of the disease. AD has been identified as

having several stages, including (a) a preclinical stage in
which the disease causes damage to the brain, but there are
no measurable symptoms; (b) mild cognitive impairment
(MCI) due to AD, in which there are noticeable changes
in cognition that are not severe enough to affect daily life
(Albert et al., 2011); and (c) dementia due to AD, in which
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there are behavioral and/or cognitive symptoms that are
severe enough to impact the individual’s abilities to function independently (Alzheimer’s Association, 2016a).
Individuals with AD and their caregivers face multiple
decisions about how to maintain safety and well-being
during the course of the disease. One of the most difficult
decisions for many is determining when individuals with
AD are unsafe to drive, and how to help them through
this transition (Alzheimer’s Association, 2008; Bronner,
Perneczky, McCabe, Kurz, & Hamann, 2016). Because
driving is a fundamental activity linked to socialization,
independent functioning, and well-being (Marottoli et
al., 2000), making the decision to stop driving is not easy.
In addition, the health consequences of driving cessation
for older adults include social isolation, health problems,
institutionalization, higher mortality, and an approximately
doubled risk of depression (Chihuri et al., 2016).
Because AD is a progressive disease, resulting in significant loss of cognitive and functional abilities, most
individuals with the disease and/or their families may
face the decision of when to stop driving. A concern is
that some individuals with AD continue to drive even
after they are unsafe, putting themselves and others at
risk for injury or death (Snellgrove, 2009). In the United
States, few laws or policies exist that help guide families
or providers when making decisions about driving safety.
For example, only 33 of 50 states have any restrictions on
driving license renewal for mature drivers (Governor’s
Highway Safety Administration, 2016). Those states with
restrictions often have minor ones, such as not allowing
renewals of the license by mail or requiring a vision test,
which may not identify individuals with cognitive problems (Governor’s Highway Safety Administration, 2016).
Driving examinations to identify if an individual is a safe
driver are often not covered by insurance (e.g., Medicare,
Medicaid) and can be cost-prohibitive, ranging from $200
to ≥$400 (American Medical Association, 2010). Even
if insurance covered the cost of testing, with 5.3 million
Americans having AD, the resources for testing would be
strained.
Not knowing when individuals with AD are safe or
unsafe to drive is risky for the individuals affected and
society. In AD, cognitive problems, such as slowed reaction times and memory problems, can impact driving
ability (National Institute on Aging, 2002). Those with
cognitive impairment have difficulty reacting and making
decisions while driving (Alzheimer’s Association, 2016b),
which can lead to getting lost while driving and difficulty
detecting and avoiding hazards, as well as increased errors
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while driving due to compromised judgment and ability to
make decisions (Ott, 2014). Determining when individuals
with dementia are not safe to drive is essential for those
individuals and society.
Even more challenging is determining when individuals
with dementia are still safe to drive, and if methods exist
to maintain their safety for a time. If individuals with
AD are safe to drive, yet have their drivers’ license taken
away prematurely, they can experience declines in health
and well-being. Conversely, individuals with dementia
may drive unsafely and cause injury to themselves and
others. As argued by Warlow (2015), “A difficult balance
has to be struck between the driver’s autonomy and ‘right
for mobility’ and the safety of everyone else on the road”
(p. 593). Society runs the risk of being put at danger from
unsafe drivers, but also of bearing the cost of expensive
testing and providing transportation for individuals who
can no longer provide it for themselves.

REVIEW
Aim
Many studies exist on driving in individuals with MCI
and AD; however, there have been few syntheses of the
literature that examine how individuals with AD, their
families, and providers determine when an individual with
MCI or early-stage dementia is safe or unsafe to drive.
Most recently, Andrew, Traynor, and Iverson (2016) conducted an integrative review on driving decision making
in individuals with dementia. Their review primarily contained sources prior to the current review (they ended
their search in 2012), and focused on how individuals
make decisions to stop driving.
No integrative reviews exist on interventions to help individuals with dementia maintain safety while driving, or interventions to help them make the decision to stop driving. Thus,
the aim of the current integrative review was to synthesize evidence exploring decisions about how individuals with earlystage AD, their families, and providers make determinations
about driving safety. The specific objectives were to determine
(a) the types of testing that should be done to decide when individuals with dementia are safe to drive, (b) interventions to
assist in driving safety, and (c) driving cessation for individuals with MCI and early-stage AD.
Search Method
A review of the literature included articles published
between January 2007 and May 2015. Databases used in
the search included CINAHL, the Cochrane Database of
Systematic Reviews, PubMed, PsycINFO, and Science
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Direct. Articles cited in the bibliographies of articles were
also explored for inclusion. Search terms used included
combinations of: dementia, early stage, Alzheimer’s disease,
mild cognitive impairment (MCI), driving, driving safety,
driving interventions, driving performance, driving assessment, driving cessation, and testing. Inclusion criteria were:
research studies (qualitative or quantitative) addressing
driving in early-stage AD (unspecified types of dementia
were included) or MCI, human studies, and those written
in English. Exclusion criteria were: articles primarily about
other causes of dementia, studies about individuals with
later stage dementia, studies primarily about caregivers,
other literature reviews, or systematic reviews. Only primary sources were included.
Search Outcome and Quality Appraisal
The initial search yielded 130 articles. The abstracts of
the articles were scanned by two reviewers to determine
their applicability related to the inclusion criteria. A total of
26 articles were found to meet inclusion criteria. Each study
was reviewed against quality appraisal criteria established
by Fisher and King (2013). The criteria included nine questions related to the methods, sample size, data collection,
analysis, ethics, validity, findings, limitations, and value of
the research. Most studies included in the current review
were quantitative studies in which a control group of cognitively normal older adults was compared to a group of
individuals with MCI and/or early-stage dementia. These
studies were overall strong methodologically, with detailed
descriptions of their measures, clear statements of the
study findings, and some discussion of validity. The most
common weaknesses were that few studies included a
power analysis to determine the appropriate sample size to
detect a difference between groups, some of the measures
lacked reliability or validity testing, many studies did not
include a discussion of research ethics, and several studies
did not discuss study limitations (Table A, available in the
online version of this article).

RESULTS
After reviewing the articles, the current authors summarized the articles in tables, identifying salient themes
from each. A list of categories was developed and collapsed based on commonalities to reveal four main
themes: (a) assessment of driving ability (n = 6), (b) neuropsychological testing and driving performance (n = 11),
(c) factors associated with driving performance and cessation (n = 5), and (d) interventions for driving and driving
cessation (n = 4). A synthesis of the results is discussed.
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Assessment of Driving Ability
One problem for individuals with AD and their families
is knowing when the symptoms of AD are severe enough
that they should consider having a driving examination.
For the past 15 years, the gold standard recommendation to assess driving ability in individuals with dementia
has been to conduct an on-the-road driving test (ORDT)
every 6 months after diagnosis (Dubinsky, Stein, & Lyons,
2000). However, this type of testing is costly and not often
covered by insurance. Knowing when testing should begin
in the disease process is important. Furthermore, the types
of driving impairments must be identified to potentially
address interventions to provide for safety. The current
authors found two studies that explored driving ability
using ORDT, three that examined naturalistic driving,
and one that used driving simulation to determine driving
impairments in individuals with early-stage AD and/or
MCI (Table 1).
On-the-Road Driving Test. Several studies have examined driving ability in individuals with AD during different
stages of the disease, adding insight into the progression
of driving impairment in AD. Evidence exists that certain
driving skills decline early in the disease. The problems
exhibited by individuals with AD and MCI include lefthand turns, maintaining proper speed, and lane control
(Wadley et al., 2009). In another study, individuals with a
Clinical Dementia Rating (CDR) score of 0.5 (questionable
dementia) were less likely to fail the driving test than those
with a CDR score of 1 (mild dementia) (Ott, Heindel, et
al., 2008). Thus, driving problems can begin early in the
disease (during MCI), but many individuals in the early
stage (CDR score = 0.5) may be able to continue driving
for a time. Driving ability appears to decline over time,
supporting the need for repeated driving assessment after
diagnosis to detect unsafe driving.
Naturalistic Driving Tests. An innovative method of
testing driving ability is using a naturalistic assessment
that involves the use of cameras and other technology to
monitor and record driving performance on a day-to-day
basis. Several studies have examined driving performance
in individuals with AD as compared to controls, and have
shown that individuals with early-stage AD have more
driving impairments than controls, are more likely to get
lost, less likely to wear a seatbelt, and more likely to drive
10 mph slower (Davis et al., 2012; Eby, Silverstein, Molnar,
LeBlanc, & Adler, 2012; Festa, Ott, Manning, Davis, &
Heindel, 2013). However, individuals with AD have been
found to limit their driving by driving fewer miles, shorter
distances, and less often at night, and by staying closer to
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To compare driving
behaviors in early-stage
dementia with controls

To examine how individuals with MCI use their
brakes at intersections

To identify self-regulatory
driving behaviors used
by older drivers and how
behaviors change with
cognitive impairment

To assess the effects of MCI
on simulated car driving
ability, and compare
driving in individuals with
MCI/AD to controls

To describe progression
of driving impairment in
individuals with early-stage
AD compared to controls

To measure driving ability
in individuals with MCI

Eby, Silverstein, Molnar,
LeBlanc, &
Adler (2012)

Devlin, McGillivray, Charlton,
Lowndes, &
Etienne (2012)

Festa, Ott,
Manning,
Davis, &
Heindel (2013)

Frittelli et al.
(2009)

Ott, Heindel, et
al. (2008)

Wadley et al.
(2009)

46 with MCI, 59 controls

44 controls, 84 with earlystage/probable AD

19 controls, 20 with mild
AD, 20 with MCI

20 with questionable or
mild AD, 20 controls

14 with MCI/early-stage
AD, 14 controls (ages 65
to 87)

26 controls, 17 with earlystage dementia

44 controls, 59 with
possible/probable AD

Sample

Used a standardized road test
coded on 5-point scale from
1 = evaluator took control of
car to 5 = optimal

ORDT, visual, motor, and cognitive testing every 6 months
for 2 to 3 years; reports of
crashes and driving violations

Battery of tests and simulated
driving test

Used composite driving
assessment scale to rate the
performance of naturalistic
driving

Cognitive and motor tests;
used driver simulator that
operated like a car

Analyzed driving data from
video, audio, and other sensors, which were placed in
vehicle

ORDT and video recordings of
naturalistic driving

Measures

Individuals with MCI scored worse on global
and discreet driving measures but were not
severely impaired compared to controls.

Controls and participants with AD declined
in driving ability over time; those with AD
declined faster. Time to failure increased with
higher CDR scores. Age and education were
predictors of failure.

Driving impaired in individuals with AD
compared to those with MCI and controls. Significantly worse on length of run, mean time
to collision, and number of off-road events. No
differences detected in number of infractions
and stops at traffic lights. Driving scores not
significantly correlated with MMSE.

Participants with AD modified driving more
frequently to most optimal conditions and had
much smaller driving space than controls. Few
safety problems for both groups.

No significant differences between groups;
trend for MCI to stop less at stop signs and
stop-sign controlled intersections.

Those with dementia drove less miles, less destinations, and less distance, and more during
the day. They got lost more, were less likely to
wear a seatbelt, and drove slower.

Fair agreement between ORDT and naturalistic
driving; participants with AD scored worse on
ORDT and naturalistic driving.

Findings

Note. ORDT = on-the-road driving tests; AD = Alzheimer’s disease; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; CDR = Clinical Dementia Rating.

To compare ORDT to naturalistic driving

Purpose

Davis et al.
(2012)

Citation

Driving Assessment Recommendations in Alzheimer’s Disease

TABLE 1

All participants were currently driving.

There were relatively few
motor vehicle crashes or
traffic violations in both
groups.

All participants were currently driving.

Only those who passed
the road test could be in
the study.

Small sample may have
influenced nonsignificant
results.

No cognitive assessment of either group
was reported. Type of
dementia not specified.

Naturalistic driving
indicated modification
of driving behaviors in
participants with AD.

Comments
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home (Eby et al., 2012). In addition, they have been found
to drive more in sunny weather versus inclement weather,
more often in residential areas, and more in light traffic as
compared to controls (Festa et al., 2013). The unique insight
of the naturalistic driving assessment in these studies is that
individuals with AD have driving problems even when not
under the pressure of road testing, and compensate for their
deficits by modifying their driving practices.
Driving Simulation. Another method of driving assessment is testing during a driving simulation, which most
frequently involves driving via a computerized display
(Casutt, Martin, Keller, & Jäncke, 2014). These studies
support those using ORDT, showing that individuals with
AD exhibit more driving errors than those with MCI and
controls (Frittelli et al., 2009), and that driving errors are
subtle but present in individuals with MCI (Devlin, McGillivray, Charlton, Lowndes, & Etienne, 2012). Thus, despite
the method of driving testing, individuals with MCI and
AD have evidence of an impaired driving performance
when compared to those without cognitive disease.
Neuropsychological Testing and Driving Performance
To drive, one must manage the mechanical demands
of operating an automobile (i.e., brakes, gas, and turn signals), simultaneously processing incoming stimuli (e.g.,
traffic signals, other vehicular traffic) while making decisions about when to turn and where to go. Consequently,
driving requires cognitive, motor, and sensory functions—
all of which may be affected by AD. There have been many
studies with the goal of identifying the neuropsychological
tests that are most predictive of driving ability. A better
understanding of the types of driving impairments demonstrated by individuals with dementia can help provide
evidence for rehabilitation measures in addition to recognizing those at risk for driving safety problems. In the current literature review, 10 studies were found that examined
the relationship of neuropsychological tests with driving
ability (Table 2).
Neuropsychological Test Batteries as Predictors of Driving
Performance. Several studies examined how a battery of
neuropsychological tests can predict driving ability, as
measured by an ORDT, in individuals with dementia. These
studies found that combinations of tests, including measures of visual–sensory function, memory, visual spatial
abilities, and speed of information processing were related
to driving performance (Anderson et al., 2012; Dawson,
Anderson, Uc, Dastrup, & Rizzo, 2009; Lafont et al., 2010).
These studies support the proposition that driving ability is
related to multiple cognitive and functional domains.
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Two studies examined the ability of a test battery to correctly identify safe and unsafe drivers. These studies found
that it was possible to correctly classify the driving ability
of participants with dementia to some degree using neuropsychological tests (Carr, Barco, Wallendorf, Snellgrove,
& Ott, 2011; Lincoln, Taylor, Vella, Bouman, & Radford,
2010). The benefit of testing in these cases is that the tests
could be used (after further validation studies) to determine when to consider a driving test or counsel an individual to stop driving.
Several research teams have examined the relationship
between performance on maze tests and driving performance. Mazes are thought to simulate the cognitive processes necessary for driving. Two studies found that maze
tests either alone (Snellgrove, 2009) or with other cognitive tests (Ott, Festa, et al., 2008) could accurately predict
driving performance via ORDT 79% to 81% of the time.
Single Tests as Predictors of Driving Performance. In an
effort to determine an efficient way to identify individuals
with AD who are at risk for driving problems, several
researchers have attempted to determine if one specific
test is most predictive of driving performance. Although
the Clock Drawing Test has been shown to correlate with
driving performance, it has been found not to be sensitive
or specific enough by itself to predict driving performance
results in individuals with AD (Manning, Davis, Papandonatos, & Ott, 2014).
One test that shows promise in identifying individuals
at risk for driving impairment is the Wechsler Digit Symbol
Substitution Test (DSST), which requires individuals to
match symbols with numbers during a timed test. The
DSST is a measure of “visuospatial perception, selective
attention, response speed, visuomotor coordination, and
incidental memory…and executive processing” (Lafont et
al., 2010, p. 160). Lafont et al. (2010) found that a DSST
score of <29 was useful for identifying safe and unsafe
drivers.
There has been some debate in the scientific literature
about whether CDR scores are sufficient for suggesting
when driving cessation should occur. The CDR is a
common test used to determine the stage of dementia,
with scores ranging from 0 = no dementia to 3 = severe
dementia. The CDR uses an interview of the patient and an
informant to determine abilities in “memory, orientation,
judgment and problem solving, community affairs, home
and hobbies, and personal care” (Morris, 2005, p. 174).
Berndt, Clark, and May (2008) analyzed the relationship between CDR and ORDT scores in individuals with
dementia and found that using dementia severity alone is
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To examine effects of navigation secondary tasks to
safety errors and cognitive
function to driving ability

To evaluate neuropsychological tests in driving
safety risk in individuals
with and without disease

To assess dementia severity
as an indicator of driving
performance to determine
when driving cessation
should occur

To develop a screening
battery for on-road performance of drivers with
dementia

To measure association of
cognition, visual perception, and motor function in
driving safety in AD

To identify cognitive tools
associated with unsafe
driving among older adult
drivers of varying cognitive
levels

Anderson et al.
(2012)

Berndt, Clark, &
May (2008)

Carr, Barco,
Wallendorf,
Snellgrove, & Ott
(2011)

Dawson,
Anderson, Uc,
Dastrup, & Rizzo
(2009)

Lafont et al.
(2010)

Purpose

Aksan et al. (2011)

Citation

23 with early-stage
AD, 20 age- and
gender-matched
controls,
36 additional
drivers without
dementia

40 with earlystage AD
(33 men, 7 women),
115 controls
(60 men, 55 women)

99 with dementia

117 with dementia
(MMSE scores 18
to 30)

185 controls,
40 with AD, 92 with
Parkinson’s disease,
29 who had a stroke

77 controls,
32 with AD, 39 with
Parkinson’s disease

Sample

Battery of neuropsychological tests and ORDT

Neuropsychological battery, motor ability, and
ORDT

Host of psychological tests
and then the dependent
variable was a pass/fail
standard road test. Used
stepwise logistic regression to determine the best
variables.

ORDT and MMSE

Battery of tests and ORDT

Battery of tests and an
ORDT. Had to memorize
a route and navigate, and
then identify landmarks
while driving (secondary
task).

Measures

Individuals with AD had lower cognitive performances
for all time and speed measures and scores worse on
the ORDT. The Wechsler Digit Symbol Substitution test
score was the best cognitive measure to detect unsafe
driving.

Those with AD only had driving and safety errors. A
composite score reflecting test performances across
multiple cognitive domains was best predictor of
driving safety.

Using a combination of the AD-8 total score, CDT, and
TMT-A or SBT time predicted accurately the majority of
those who would fail the ORDT.

Those who passed ORDT had higher MMSE scores than
those who failed. Drivers who failed ORDT were also
older. One third of those with very mild and one half of
those with early-stage dementia passed the test.

Visual–sensory function, memory, visual spatial abilities, speed of processing related to ORDT scores

Individuals with AD and Parkinson’s disease scored
worse than controls on all driving measures. Secondary
tasks increased driving errors. Speed of processing
predicted on-task safety errors after controlling for
other factors. Visual sensory function, memory, and set
shifting (TMT-B) predicted secondary task performance.

Findings

Neuropsychological Tests as Predictors of On-the-Road Driving Tests (ORDT)

TABLE 2

All participants were
currently driving.

All participants were
currently driving.

All participants were
identified as needing a
driving evaluation.

Converted MMSE
scores to CDR and had
no description of type
of dementia.

All participants were
currently driving.

All participants were
currently driving.

Comments

Davis & Ohman
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To determine if computerized maze performance
is predictive of on-road
driving performance

To describe the on-road
driving performance of
individuals with AD/MCI
and validate a new maze
task

To determine if verbal,
audio, or combination of
both assisted individuals
with AD in driving

Ott, Festa, et al.
(2008)

Snellgrove (2009)

Yi, Lee, Parsons, &
Falkmer (2015)

Sample

28 with MCI due to
AD or early-stage
AD

23 with MCI,
92 with early-stage
dementia

45 controls,
65 with probable
AD, 23 with possible
AD

47 healthy older
adults, 75 with cognitive impairment
with possible or
probable AD (CDR
scores = 0.5 to 1)

74 recruited,
65 completed
ORDT, all had
dementia except
one with MCI

Measures

Cognitive tests and simulated driving test using GPS
in audio, audio plus visual,
and visual only settings

Maze task, interview, and
ORDT

Computerized maze tasks,
other neuropsychological
test battery, and ORDT

CDT and ORDT

Standardized battery of
tests and ORDT

Findings

Audio and audiovisual settings on GPS were most
effective at helping individuals drive; visual attention
was related to performance.

70% of participants failed the driving test.
Approximately one half with MCI and 75% of those
with early-stage dementia failed the road test. Maze
task correlated predicted on-road driving ability.
Accurately identified 79% of the drivers.

Road test scores significantly correlated with total time
for five mazes. Logistic regression best model: maze
total time + Hopkins verbal learning tests trial 1+ trials
A + Age. Correctly classified participants 81% of the
time.

Findings revealed that CDT was significantly correlated
with the driving score but receiver operator curve
analyses showed limited clinical use of the CDT as a
screening instrument for impaired on-road driving
performance.

A standardized battery of neuropsychological tests
predicted driving performance with 76.2% accuracy.

Comments

24% of participants
had simulator sickness and dropped
out. Conditions were
not randomized. No
control group.

Dementia type was
not specified. ORDT
failure rate was higher
than that in other
studies perhaps due
to varying types of
dementia.

12 participants who
could not complete
the road test and 11
who could not complete the computerized mazes withdrew.

All participants were
currently driving.

All participants were
currently driving.

Note. AD = Alzheimer’s disease; TMT = Trial Making Test; MMSE = Mini-Mental State Examination; CDR = Clinical Dementia Rating; AD-8 = Ascertain Dementia 8-Item Informant Questionnaire; CDT = Clock Drawing Test; SBT = Short Blessed Test;
MCI = mild cognitive impairment; GPS = global positioning system.

To determine if CDT predicts driving performance

Manning, Davis,
Papandonatos, &
Ott (2014)

Purpose

To evaluate the accuracy of a test battery to
predict driving ability in
individuals with AD, and
to assess whether it could
be improved by being
shortened

Lincoln, Taylor,
Vella, Bouman, &
Radford (2010)

Citation

Neuropsychological Tests as Predictors of On-the-Road Driving Tests (ORDT)

TABLE 2 (CONTINUED)
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not sufficient in assessing driving ability.
Factors Associated With Driving Performance and
Cessation
Because driving safety is a concern for many individuals
with AD, research about ways to approach driving cessation and help those with AD and their families during
the transition is imperative. The current authors found
five studies that examined the process of decision making
about driving cessation (Table 3).
Provider Comfort and Involvement With Driving Cessation. It is important that health care providers are prepared to discuss driving issues with their patients who have
dementia. However, providers may not broach the problem
with their patients. One study found that only 59% of physicians discussed driving with their patients with dementia
and referred them for driving evaluation; physicians who
addressed driving were in practice longer and stated they
viewed addressing driving in their older adult population
as part of their role (Adler & Rottunda, 2011). Adler and
Rottunda (2011) recommended that “outreach efforts to
inform and educate physicians to driving and dementia
issues are needed” (p. 62).
Driving Decision Making for Individuals With
Alzheimer’s Disease and Their Carers. It is important to
have an understanding of how individuals with dementia
and their families make decisions about when to stop
driving. Two qualitative studies found that driving cessation tends to occur in stages, ranging from noticing driving
problems that affect safety to making adjustments to compensate for driving problems to finally making a decision
to quit driving (Adler, 2010; Liddle et al., 2013). Surprisingly, Adler (2010) found that individuals with AD had not
made plans for the future, reporting they hoped driving
cessation would just happen.
Family members play a major part in determining when
individuals with dementia should stop driving. Caregivers
in one study rated their loved one with dementia on
a survey as having fair, poor, or unsafe driving ability
(Croston, Meuser, Berg-Weger, Grant, & Carr, 2009).
Family members reported the majority of patients with
dementia who stop driving do so because of encouragement from family and physicians due to declining cognitive abilities (Croston et al., 2009).
Many studies have reported barriers to driving cessation as a lack of insight to problem driving, the driver’s personality, a belief that the individual with dementia was still
safe on the road, concern of isolation without the ability
to drive, and reluctance of the family to address driving
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cessation. Croston et al. (2009) found more than one half
of patients retained their drivers’ license although they no
longer drove; the reasons for this were not investigated.
The studies reviewed indicated that there was a lack of support from the medical community when assisting patients
with AD to cease driving. Few patients had a discussion
or record of a discussion with their health care provider
regarding this issue. Although driving screening was
believed to be helpful in identifying the appropriate time to
quit driving (Liddle et al., 2013), few patients were referred
for driving evaluation (Adler, 2010; Croston et al., 2009).
Adler (2010) found that an earlier diagnosis of dementiarelated disease would have helped the dyad make longterm plans, such as when driving should cease. Liddle et
al. (2013) found that dyads received conflicting advice and
varying support between medical and community services.
Seiler et al. (2012) investigated the influence of cognition, function, and behavior on the decision to give up
driving in participants with various types of dementia.
Caregivers stated that it was their concerns about the individual’s with AD driving safety that were the main impetus to stop driving. A small percentage of individuals with
AD stopped driving due to accidents and the revocation of
their drivers’ license. One third of those with any type of
dementia continued to drive. Typical neuropsychological
indicators of dementia were not found to be helpful in
determining driving cessation.
Interventions for Driving and Driving Cessation
Evidence indicates that many individuals with MCI and
AD continue to drive for some time after diagnosis, which
places importance on interventions to improve driving
safety. In addition, interventions to help individuals and
their families determine how to stop driving and how to
adjust to this major life change are needed. The search for
interventions yielded only four studies that looked at ways
to improve driving ability or help individuals with AD
adjust to driving cessation (Table 4).
Cholinesterase Inhibitors. Cholinesterase inhibitors
(ChEI) are frequently given to individuals with AD to
delay some of the cognitive symptoms of the disease.
Daiello et al. (2010) investigated the use of ChEI on visual
attention and executive function in individuals with mildto moderate-stage AD using a driving simulation test.
Three groups were compared, including newly diagnosed
AD participants who received ChEI at the beginning of
the study, those who were already taking ChEI, and those
who were not taking ChEI. The results showed several benefits of ChEI, including increased tracking ability in the

To understand driving
status of individuals
with dementia and gain
insight on driving retirement

To determine the
best way to support individuals with
dementia and driving
cessation

To study influences of
240 participants with
cognition, function,
various dementias
behaviors, and caregiver
characteristics on driving
cessation

Croston,
Meuser, BergWeger, Grant,
& Carr (2009)

Liddle et al.
(2013)
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Seiler et al.
(2012)

4 retired drivers, 11 caregivers, 15 health care
providers

119 patient/caregiver
dyads

239 physicians who
worked with older adults

To explore physicians’
views on discussing
driving with patients
with dementia and their
caregivers

Sample
20 drivers with dementia
and their caregivers,
25 caregivers of former
drivers

Adler &
Rottunda
(2011)

Purpose

To investigate how decisions are made about
driving in individuals
with dementia and their
caregivers

Adler (2010)

Citation

Questions for
patients and
caregivers, cognitive test battery,
other measures

Interview

Questionnaire

65-item
questionnaire

Focus groups

Measures

Approximately 60% of those with AD stopped driving. Cause
of cessation for most participants was related to caregiver
judgment of driving ability and not car crashes or other factors.

Three stages of driving cessation included: early phase
(driving concerns are noticed), crisis phase (high-risk driving
and conflict about driving), and adjustment phase (individual
with dementia adjusts to driving cessation). Participants
recalled receiving conflicting advice, varying support. Sense
of loss was also a prominent concern. Driving screening was
reported to be helpful in identifying the appropriate time to
quit driving.

Caregivers concerned about driving ability of individuals
with dementia. Driving cessation occurred due to recognition of cognitive decline and encouragement from family and
providers. Barriers for driving cessation included poor insight
into risks, personality and beliefs of safe driving, fear of isolation if unable to drive, hesitance of family to have a discussion,
and no discussion from the provider about cessation.

59% of physicians surveyed discussed driving with patients
and referred them for driving evaluation. Those who
addressed driving were in practice longer and saw driving
counseling as part of their role.

Themes included red flags noticed, compensation strategies
developed, and plans to quit made. Spouses of former drivers
had difficulty with the transition and were often instigators of
driving cessation. Recommended that professionals should
provide information and assist in conversations.

Findings

Factors Associated With Driving Performance and Cessation

TABLE 3

Comments

Confirmed 33% of patients
with dementia continued
to drive. No significant link
between type of dementia
and not driving.

Driving cessation was an
individual process.

One half of patients kept
their license active; reasons
were not investigated.
Providers played a key role
in driving cessation discussions.

Resource available:
American Medical Association’s Physician’s Guide to
Assessing and Counseling
Older Drivers

Suggestion to combine
needs of patients with
expertise of professionals to
work together when making
driving decisions.
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10

To test a program to help
individuals with dementia
and caregivers cope with
the loss of driving

To develop and evaluate
a caregiver intervention
for managing driving
decisions in those with
dementia

To examine the effect of
visual and verbal cues
on simulated driving
performance

Dobbs, Harper, &
Wood (2009)

Stern et al. (2008)

Yi, Lee, Parsons, &
Falkmer (2015)

28 individuals with mild/very
mild AD

31 caregivers in the active
intervention, 23 caregivers who
received written information,
12 controls

47 individuals with dementia
who had license revoked,
30 caregivers

24 individuals with new diagnosis of early-stage AD, 35 with
AD on ChEI, 35 with AD not
on ChEI

Sample

Battery of cognitive
tests, driving simulator
test

Intervention with
posttest

Measures of cognition,
depression, interview
data

Simulated driving test,
visual search task,
maze task

Measures

Note. ChEI = cholinesterase inhibitors; ORDT = on-the-road driving test; DCSG = driving cessation support group; TSG = traditional support group.

To assess effects of ChEI
on driving tasks

Purpose

Daiello et al. (2010)

Citation

Driving performance was best in the audio-only
setting, moderate in the normal setting, and
lowest in the visual-only setting.

Active intervention group rated themselves
significantly higher in their ability to handle
driving cessation issues with the individual with
dementia. They reported having an easier time
accepting the circumstances, were more prepared to discuss driving cessation, and actively
communicated driving cessation with care
recipients with dementia.

The DCSG group had improved depression,
quality of life, memory, and behavior compared
to TSG. Loss of driving ability handled better
in the DCSG group than in the TSG group. The
DCSG group stated they were better equipped
to cope with the loss of their driving privileges
and were more likely to recommend the group
to others.

Benefits of ChEI included increased tracking
ability in the simulated driving test, more
accurate single-task activities, improved visual
search accuracy, and faster completion of the
mazes

Findings

All participants currently
drove at least 2 hours
per week. Twenty-four
percent of initial sample
withdrew due to motion
sickness.

Based off the At the
Crossroads intervention
(The Hartford, 2007)

11 with early-stage AD
withdrew due primarily
to intolerance. Any ChEI
was acceptable. Simulation only, not ORDT.

Comments

Interventions to Help Individuals With Alzheimer’s Disease (AD) or Mild Cognitive Impairment (MCI)
Adjust to Driving Cessation or Improve Driving Ability

TABLE 4

Davis & Ohman
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simulated driving test, more accurate single-task activities, improved visual search accuracy, and faster completion of the mazes. Although the study did not directly test
driving ability in an ORDT, it provided promising results
supporting the possible effect of ChEI on the cognitive
functions necessary for driving.
Global Positioning Systems. One study conducted by Yi,
Lee, Parsons, and Falkmer (2015) examined the effect of
visual and verbal cues plus verbal global positioning systems (GPS) on a simulated driving test in individuals with
very mild to mild AD. Results showed a significant difference between the GPS conditions, with the best driving
performance in the audio-only condition. The researchers
hypothesized that the increased demands on visual attention with the visual GPS settings could have impaired the
driving performance.
Support Groups. Two studies examined the effect of
support groups on adjustment to driving cessation. Dobbs,
Harper, and Wood (2009) investigated the benefit of two
types of support groups (driving cessation–specific support
group versus general AD support group) for individuals
with early-stage dementia who had their drivers’ license
revoked. Although all participants rated the support groups
as helpful, the findings supported the driving cessation–
specific support group as better at equipping participants
to cope with the loss of their driving privileges.
Although the current literature review is limited to
studies about individuals with dementia and excluded
studies about caregiving, one study with caregivers was
included because it assessed the effect of an intervention
involving caregiver education on addressing driving issues
in individuals with AD. Stern et al. (2008) conducted a
randomized controlled trial with caregivers of individuals
with MCI, AD, or other dementias, in which participants
were randomly assigned to either a psycho-educational
intervention, written information, or control group.
Results showed that caregivers in the educational intervention group scored higher in self-efficacy, communication,
and ability to address driving cessation with the individual
with dementia than those in the other two groups. In
addition, almost all of those in the education group
reported speaking with their loved ones about driving
cessation during the course of the study. Thus, Stern et al.
(2008) concluded that there was strong evidence that the
intervention was effective in helping caregivers address the
issue of driving cessation with their loved ones and that
written materials alone are not as effective as intervention.
Taken together, the two studies on support groups give
beginning evidence that support groups aimed specifically
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at driving cessation strategies may be beneficial for individuals with dementia and their families.

DISCUSSION
The current literature review focused on individuals
with MCI and early-stage AD, which is a time when many
of them are still driving. A consistent finding was that
some individuals with MCI or early-stage AD may be able
to drive safely for a time; a diagnosis of MCI or early-stage
AD does not necessitate driving cessation immediately. As
the disease progresses, individuals with MCI or AD are
more likely to have impaired driving (Ott, Heindel, et al.,
2008; Wadley et al., 2009); thus, driving assessment should
be ongoing.
Findings from the current review do not completely
answer the question of how to know when individuals
with MCI or AD are safe to drive. A weakness of the
existing literature is that most driving studies only include
individuals who are still driving and who have been formally diagnosed with MCI or AD (often at a memory
clinic). Because only approximately one half of individuals
in the community who have AD are formally diagnosed
(Alzheimer’s Association, 2015), the studies are limited in
their generalizability. Only one study looked longitudinally
at how driving changed over time for controls and individuals with AD (Ott, Heindel, et al., 2008). However, this
study also only included those who were currently driving,
which is necessary when doing an ORDT to avoid injury.
However, the literature does not provide an explanation for
how individuals with MCI or AD who are still driving are
different from those who have stopped driving.
One way to help identify individuals who need a driving
assessment may be to conduct neuropsychological testing.
Many neuropsychological tests show a correlation with
driving performance, but no single neuropsychological
test or test battery is sufficient to determine driving safety.
A combination of tests, including those for visual spatial
ability, memory, information processing, and executive
functioning may support the clinician’s decision about
whether a road test is necessary (Aksan et al., 2011;
Anderson et al., 2012; Carr et al., 2011). In addition, performance on these tests may eventually help provide information about future types of interventions, such as specific
cognitive training exercises, that may help improve driving
ability in individuals with MCI or AD.
Evidence exists that carers of individuals with dementia
find driving cessation to be a long process that largely falls
on them to address, yet they are not always prepared for
this task or supported by health care providers (Adler,
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2010; Croston et al., 2009; Seiler et al., 2012). Individuals
with AD and their carers look to their providers for help
with driving cessation and it is a major concern for many.
Because driving skills decline progressively and start early
in the disease process, health care providers must assess
driving concerns for all patients who have MCI or AD.
Some individuals have significant driving safety problems
even with MCI (Frittelli et al., 2009; Wadley et al., 2009).
Health care providers must be cognizant of risk factors
that precipitate unsafe driving and collaborate with carers
to determine the safest course of action when addressing
the need to cease driving. Care providers must be knowledgeable about the expected trajectory of driving ability for
individuals with MCI/AD, along with the resources and
referrals in the community that can help provide support
for patients and their families.
Few studies examined interventions to help individuals
with AD drive more safely or maintain driving ability.
Only two studies were found that examined ways to help
individuals with dementia drive more safely. One study
examined the effect of ChEI (Daiello et al., 2010) and the
other examined different types of GPS displays (Yi et al.,
2015). The lack of intervention studies is possibly due to
the assumption that once individuals are diagnosed with
AD, they cease driving. Until 2010, the prevailing clinical
recommendation was that individuals with early-stage
dementia should be counseled to quit driving due to safety
concerns (Lyketsos et al., 2006). Currently, the American
Academy of Neurology has practice recommendations
that give guidance on assessing individuals with dementia
for driving safety, which state that the stage of dementia,
caregiver concerns about the patient’s driving, driving history, driving behaviors (e.g., reduced driving), personality
characteristics, and Mini-Mental State Examination scores
(<24) are indicators of potentially unsafe driving (Iverson
et al., 2010). Thus, the recommendation is no longer that
individuals with AD should be automatically counseled to
quit driving.
Individuals with AD have a disease that affects cognitive abilities, but they are also aging. There has been substantial research on the effects of aging on driving, which
is likely applicable to individuals with AD. For example,
there are evidence-based occupational therapy guidelines
about improving driving for older adults (Stav, 2015), in
which in-class educational sessions and individualized
on-the-road training are rated the highest level of evidence to reduce unsafe driving in older adults. In addition,
interventions such as cognitive training, physical fitness
training and exercises, simulator training, and automobile
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modifications are recommended to improve safe driving.
These interventions could be tested in individuals with AD
along with modifications to support cognitive ability.
There is beginning evidence that support groups are
effective in helping individuals with dementia and their
caregivers address and adjust to driving cessation. One
study found that engaging in a formal driving support
group after the loss of a driver’s license helped individuals
with AD cope with the transition (Dobbs et al., 2009). In
addition, supporting caregivers with a psycho-education
group class specifically focused on driving cessation may
improve their ability to address and cope with driving cessation with their loved ones with dementia (Stern et al.,
2008). The common feature of these two studies is that the
intervention was specifically aimed at driving cessation
versus a general support group for dementia.

LIMITATIONS AND STRENGTHS
There are several limitations that must be considered
in this review. The review only included English language studies, which may have limited some of the available knowledge about the topic. In addition, most studies
included only participants who were still driving, thus the
significant cognitive, functional, and behavioral changes
that occurred prior to driving cessation were unable to
be detected. A weakness of many of the studies is that
they included small convenience samples of individuals
with AD/MCI. These individuals, often coming from a
specialty memory clinic, may be different than those who
have AD/MCI but are not diagnosed early in the disease.
Many studies used ORDT, but did not indicate whether
the driving evaluator was blinded to the study group,
which may also have induced some bias. Some studies
did not clearly indicate participants’ diagnoses (i.e., type
of dementia and stage), and several did not use standardized criteria for diagnosis, making the interpretation of the
results challenging.
A strength of the current review is that it included qualitative and quantitative studies to give a breadth and depth
to the understanding of driving in dementia. According
to Whitmore and Knafl (2005), an integrative review that
uses different types of sources “contributes to the presence
of varied perspectives on a phenomenon of concern and
has been advocated as important to nursing science and
nursing practice” (p. 547). The current integrative review
was based on a systematic literature search, clear inclusion and exclusion criteria, evaluation of the literature
(including quality), and synthesis of the studies using a
thematic method. Using a clear and systematic approach
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to the literature review enhances rigor (Whitmore & Knafl,
2005).

PRACTICE IMPLICATIONS
Practice implications from the current integrative
review include:
• Early diagnosis of MCI and AD should be advocated to
address driving abilities early in the disease (Davis et al.,
2012; Frittelli et al., 2009).
• A diagnosis of MCI or early-stage AD should not
automatically result in a loss of driving privileges; some
individuals with MCI and early-stage AD are safe to
drive for a time (Ott, Heindel, et al., 2008; Wadley et al.,
2009).
• ORDT remain the gold standard for driving assessment.
However, neuropsychological testing involving visual–
sensory function, memory, visual spatial abilities, and
speed of information processing may inform practitioners of a need for testing (Aksan et al., 2011; Anderson
et al., 2012; Carr et al., 2011).
• Individuals with MCI/early-stage AD require routine
assessment of driving ability (Ott, Heindel, et al., 2008).
• Health care providers may benefit from education about
driving in dementia so that they have the skills necessary to counsel patients and families (Adler & Rottunda,
2011).
• Family members are almost always involved in the
driving decision making, yet would value more provider
input in the decision (Adler, 2010; Croston et al., 2009;
Liddle et al., 2013; Seiler et al., 2012).
• Support groups aimed at driving cessation and adjustment may help individuals with dementia and their
families to have the resources necessary to make appropriate driving decisions (Dobbs et al., 2009; Stern et
al., 2008).

SUGGESTIONS FOR FUTURE RESEARCH
The current authors have several suggestions for
research. Researchers should use a standardized definition of MCI and AD when classifying participants.
Several studies did not clearly classify the type or stage
of dementia. The cause of the dementia (e.g., AD, vascular) should be identified for all participants and included in analysis. Longitudinal designs should be used
to track the progression of the disease over time (before
driving cessation) in relation to cognitive performance
and other factors, eliminating the problem of only including existing drivers in studies. In addition, the use
of driving simulators to test driving ability can be used
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in all individuals without having to be concerned about
safety.
Because individuals with AD and MCI often continue
to drive, intervention studies to help them maintain safety
are needed. Safety studies could include multicomponent
interventions, such those focused on functional ability,
in-car safety technology, cognitive exercises aimed at
deficient cognitive mechanisms, and counseling to limit or
modify driving behaviors. Because one study found that
ChEI impacted the cognitive processes involved in driving
(Daiello et al., 2010), this should be studied further to
determine its efficacy in prolonging safe driving in individuals with AD. Further studies analyzing the effects of
GPS on driving are necessary to determine if this is a feasible intervention to keep drivers with early AD safe while
driving.
In terms of driving testing, research on alternatives to
ORDT and/or the correct timing of an ORDT is needed.
It is not known how many individuals with dementia are
tested or how many barriers exist to testing, such as cost
and fear of losing one’s license. Policies regarding standardized driving testing in adults with AD and financial
coverage of ORDT should be considered. Appropriate
screening tools for primary care providers should be
developed and tested for an indication for further driving
assessment. Specific cutoff scores for cognitive tests should
be tested to make them applicable for practice. Methods
to effectively educate health care providers, patients, and
families about driving safety and cessation must be studied
further.

CONCLUSION
The current literature review shows the complex nature
of driving cessation in early-stage AD. There is more work
to be done in this area to best support individuals with dementia and their carers. No single cognitive or physical test
is a strong predictor of driving ability. Diagnosis of MCI
or AD does not necessarily mean that individuals must
immediately stop driving. Evidence suggests that some individuals with MCI or early-stage AD can drive safely for
a time, but that as the disease progresses, driving ability
declines. Families look to providers to assist with crucial
driving conversations when individuals with AD become
unsafe to drive. All caregivers require support from the
health care team and community when making difficult
decisions, such as when it is time for the individual with
dementia to stop driving. Further studies are required to
test new technology and other interventions for their role
in driving safety.
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